Back to School: How biopharma can reboot drug development. Access exclusive analysis here

REG1: Phase I started

Regado began the open-label, U.S. and Argentinean Phase I REVERSAL-PCl trial

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE